← Leaderboards
Cory Berkland
University Of Kansas Lawrence
$3,518,234
Attributed
$4,586,039
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,586,039 · 14
By mechanism
R43$1,751,286 · 5
R01$1,372,541 · 1
P20$875,479 · 6
R56$381,304 · 1
R03$205,429 · 1
Top collaborators
- Maria Flynn3 shared
- Milind Singh3 shared
- Ronald Arthur Beyerinck2 shared
- Nathan H Dormer2 shared
- David Dumbauld2 shared
- David N. Newbold2 shared
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Michael Scott Detamore$4,150,847
- Marcus Laird Forrest$3,294,230
- Elias K Michaelis$4,637,760
- Keith R. Buszek$1,812,117
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBaseDesignDoseNanoparticleControlled ReleaseSiteResearch PersonnelInnovationPropertyTechnologyPositioning AttributeMouse ModelAnimalsSignal TransductionIn VivoImmunePolymersPerformanceCellsTissuesGrantParticleFunding
Grant awards (20)
Preparing BBI-001 as an oral, non-absorbed iron chelator for prevention of iron overload$299,359
R43 · FY2021 · HL · contact PI
Integrative colloidal gels for cranial defect repair$296,742
R01 · FY2015 · DE · contact PI
Integrative colloidal gels for cranial defect repair$359,563
R01 · FY2014 · DE · contact PI
Integrative colloidal gels for cranial defect repair$357,082
R01 · FY2013 · DE · contact PI
Targeted nanoscale antigen arrays for treating autoimmune diseases$381,304
R56 · FY2012 · AI · contact PI
Integrative colloidal gels for cranial defect repair$359,154
R01 · FY2012 · DE · contact PI
Precision Particle Fabrication-enabled Betamethasone-loaded Microspheres for Tran$287,056
R43 · FY2012 · DC
Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric$216,020
R43 · FY2012 · HD
Expanding Precision Particle Fabrication Technology for the Widespread Control of$345,672
R43 · FY2011 · RR
Multi-day Pain Management Therapy with Novel Injectable Formulation$253,678
R43 · FY2011 · DA
Expanding Precision Particle Fabrication Technology for the Widespread Control of$349,501
R43 · FY2010 · RR
BIODEGRADABLE NANOPARTICLES FOR AIDS GENE THERAPY$267,113
P20 · FY2009 · RR · contact PI
Nanoparticle targeting of ICAM-1 as a potential treatment for Rheumatoid Arthriti$68,342
R03 · FY2009 · AR · contact PI
BIODEGRADABLE NANOPARTICLES FOR AIDS GENE THERAPY$246,117
P20 · FY2008 · RR · contact PI
Nanoparticle targeting of ICAM-1 as a potential treatment for Rheumatoid Arthriti$67,991
R03 · FY2008 · AR · contact PI
BIODEGRADABLE NANOPARTICLES FOR AIDS GENE THERAPY$252,428
P20 · FY2007 · RR · contact PI
Nanoparticle targeting of ICAM-1 as a potential treatment for Rheumatoid Arthriti$69,096
R03 · FY2007 · AR · contact PI
TRACEABLE CANCER-TARGETED NANOPARTICLES FOR LOCALIZED CHEMOTHERAPY$33,503
P20 · FY2007 · RR · contact PI
TRACEABLE CANCER-TARGETED NANOPARTICLES FOR LOCALIZED CHEMOTHERAPY$61,492
P20 · FY2006 · RR · contact PI
TRACEABLE CANCER-TARGETED NANOPARTICLES FOR LOCALIZED CHEMOTHERAPY$14,826
P20 · FY2005 · RR